Results
1 -
10 of
74Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemia, Cancer Chemotherapy and Pharmacology Redox Activation of Benzotriazine N-Oxides: Mechanisms and Potential as Anticancer Drugs, Selective Activation of Drugs by Redox Processes The Production of Hydroxyl and Semiquinone Free Radicals During the Autoxidation of Redox Active Flavonoids, Oxygen Radicals in Biology and Medicine Recent Advances in the Discovery and Development of Flavonoids and their Analogues as Antitumor and Anti-HIV Agents, Flavonoids in the Living System Tumour Blood Flow and Its Modulation: Implications for Bioreductive Drug Activity in vivo, Selective Activation of Drugs by Redox Processes ASA404 (DMXAA): New Concepts in Tumour Vascular Targeting Therapy, Vascular Disruptive Agents for the Treatment of Cancer Vascular Disruptive Agents in Combination with Radiotherapy, Vascular Disruptive Agents for the Treatment of Cancer Identification and Development of Vascular Disrupting Agents: Natural Products That Interfere with Tumor Growth, Natural Products and Cancer Drug Discovery Combretastatins Novel Vascular targeting Drugs for Improving Anticancer therapy, Angiogenesis 31P and 2H MRS Studies of Flavone Acetic Acid and Analogues, Magnetic Resonance in Experimental and Clinical Oncology